Arrowhead Pharmaceuticals, Inc.
ARWRBiotechnology
$60.49+0.47%As of Oct 29vs prior close
- Market cap
- $8.5B
- P/E (TTM)
- –
- From 52W high
- −32.48%
- EPS (LTM)
- -$2.18
- Revenue (LTM)
- $669.5M
- Net margin
- -47.79%
Nomior Score
52
Steady ProfileSpeculativeTop 45% of the scored universe
Growth35
Quality46
Value62
Momentum81
Resilience37
Growth
+158.97%revenue a year over 9 fiscal years
YE16 $158.3KLTM $669.5M
Connections
Revenue to profitQ3 YE26
The operating loss was 226% of revenue, narrower by 370 pts on a year.
Who owns it
2funds, 1 tracked portfolio